News
No Christmas present for Sanofi, as FDA turns down MS drug
FDA has turned down Sanofi's oral BTK inhibitor tolebrutinib for multiple sclerosis, despite suggesting earlier it would delay a decision until 2026.
News
Biosimilars unlock use of bevacizumab in bowel cancer by NHS
More than 20 years after its approval, NICE has backed the use of bevacizumab as a treatment for colorectal cancer for the first time.
News
CMS aims for broader GLP-1 access via federal programmes
CMS has revealed a new, voluntary access programme that aims to broaden the use of GLP-1 agonist medicines for diabetes and obesity.
News
Trump raises spectre of drug pricing mandates for Medicare
CMS unveils two more programmes in the Trump administration's efforts to cut drug prices, which have not been well received by the pharma industry.
News
Novo Nordisk gets FDA okay for Wegovy pill
The FDA has delivered a gift to Novo Nordisk ahead of the holiday season, with the prompt approval of its Wegovy pill.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
